About Dr. Guerrieri

About Dr. Guerrieri

NIH photo_01-22-16Gioia M.Guerrieri, DO, DFAPA, is a medical doctor, founder of Well-Minded, and is a Distinguished Fellow of the American Psychiatric Association. Dr. Guerrieri is specialized in Women’s Behavioral Health and completed a 3-year research fellowship in Reproductive Psychiatry in addition to medical school and residency.  She has been in practice for over 10 years and is board-certified in adult psychiatry and addiction medicine. 

With a background in the Arts, Fitness, and Osteopathic Medicine (and with specific expertise in psychopharmacology), Dr. Guerrieri is a collaborative physician who incorporates creative problem solving to help each of her patients establish and meet their goals in a non-intimidating environment. Dr. Guerrieri is also committed to sharing health concepts with her patients and is a certified yoga instructor and a member of the American College of Lifestyle Medicine. 

Dr. Guerrieri transferred to the Washington DC area in 2011, from the Mayo Clinic, for the National Institutes of Health (NIH)/ National Institute of Mental Health (NIMH).  She was one of two residents in the country to be invited by the NIMH to complete her 4th year of psychiatry residency in tandem with her first year of clinical research. At the NIMH, Dr. Guerrieri completed a clinical research fellowship in Behavioral Endocrinology (Reproductive Psychiatry), where she studied the effect of hormones on mood and behavior.  Dr. Guerrieri has served as an Associate Investigator on clinical trials in Reproductive Endocrine-Related Mood Disorders and Principal Investigator on a funded study evaluating biomarkers in perimenopause-onset depression. In addition, she served as a Clinical Advisory Board Member for the International Association for Premenstrual Disorders (IAPMD). Dr. Guerrieri is also a writer and gives talks on a variety of issues related to maintaining mental wellness.  She has been recognized for her dedication to patient care and mental health research and loves to incorporate teaching and psychoeducation in the scope of her practice.

Appointments, Education, & Training
Appointment – Food and Drug Administration
Appointment – Special Volunteer, NIMH (2015-2019)

Fellowship – NIH/NIMH, Behavioral Endocrinology (Reproductive Psychiatry), Bethesda, MD (2011-2015)
Residency – NIH/NIMH, Behavioral Endocrinology (Reproductive Psychiatry), Bethesda, MD (PGY-4)
Academic Appointment – Instructor of Psychiatry, Mayo Clinic, Rochester, MN
Residency – Mayo Clinic, School of Graduate Medical Education, Department of Psychiatry and Psychology, Rochester, MN (PGY-2, PGY-3)
Internship – Mayo Clinic, School of Graduate Medical Education, Department of Psychiatry and Psychology, Rochester, MN (PGY-1)
Medical School – University of New England College of Osteopathic Medicine, Biddeford, ME

Licensures & Certifications
Medical Licensure, Maryland Board of Physicians and Surgeons; unrestricted, full
Board-Certified, American Board of Psychiatry and Neurology, Psychiatry
Board-Certified, American Board of Preventive Medicine, Addiction Medicine
Certified Yoga Instructor, Level 200
Certificate – Clinical Research Curriculum, National Institutes of Health
Certificate – FDA/Duke Health Informatics Short Course for clinical informatics

Select scientific publications
Schmidt PJ, Wei, SM, Martinez PE, Ben Dor R, Guerrieri GM, et al. The Short-term Effects of Estradiol, Raloxifene     and a Phytoestrogen in Women with Perimenopausal Depression. Menopause. 2021.
– National Curriculum in Reproductive Psychiatry (NCRP): Perinatal Anxiety Module. 2019
– Muo IM, MacDonald SD, Madan R, Park S, Gharib AM, Martinez P, Walter M, Bernstein SP, Rodante J, Courville AB, Walter P, Cai H, Glicksman H, Guerrieri GM, et al. An Exploratory Study of The Effects of Roflumilast, A Phosphodiesterase 4 Inhibitor, on Insulin Sensitivity in Adults with Prediabetes and Overweight/Obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. May, 2019 https://www.dovepress.com/articles.php?article_id=46071
Wariso BA, Guerrieri, GM, Thompson K, et al. Depression during the Menopause Transition: Impact on Quality of Life, Social Adjustment, and Disability. Archives Women’s Mental Health, December, 2017 https://www.ncbi.nlm.nih.gov/pubmed/28000061
Guerrieri GM, Wakim PG, Keenan PA, Schenkel LA, Berlin K, Gibson CJ, Rubinow DR, Schmidt PJ. Sex differences in visuospatial abilities persist during induced hypogonadism. Neuropsychologia. 81 (2016) 219-229 http://www.ncbi.nlm.nih.gov/pubmed/26719236
– Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR. Effects of Estradiol Withdrawal on Mood in Women with Past Perimenopausal Depression. JAMA Psychiatry. June, 2015 http://www.ncbi.nlm.nih.gov/pubmed/26018333
Guerrieri GM, Martinez PE, Klug SP, Haq NA, Vanderhoof VH, Koziol K, Popat V, Rubinow DR, Schmidt PJ, Nelson LM. Effects of Physiologic Testosterone Replacement on Quality of Life, Mood, and Self-Esteem in Women with Spontaneous 46, XX Primary Ovarian Insufficiency.  Menopause. Vol 21.9 September, 2014 http://www.ncbi.nlm.nih.gov/pubmed/24473536

Select Invited Talks

Regulatory Challenges in the Drug Development for Neonatal Opioid Withdrawal Syndrome. NIH HEAL Initiative: Toward the Use of Buprenorphine in Infants: Scientific and Practical Considerations, Bethesda, MD, 8/25/2020*
Well-Minded Approaches for Remote Work. Association of International Certified Professional Accountants, 4/2020
Diagnosis and Management of Perimenopausal Anxiety and Depression (CME). Psychiatry Network 2019 Women Physicians Conference, Leesburg, VA, 9/27/2019
Keynote Address, UNECOM Student Research Forum, University of New England, Biddeford, ME, 9/13/2019

Panel Moderator: FDA Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender workshop. 9/27-28/2018*
Networking for Biomedical Careers in Academia and Beyond. NIMH Intramural Office of Fellowship Training, Bethesda, MD. 5/3/2017*
Psychopharmacology in and treatment modalities for Perinatal Mood and Anxiety Disorders Workshop (CEU/CEH). Department of Behavioral Health Training Institute, Washington, DC. 5/10/16

When does Blue Become Dark Blue? Understanding possible mood changes and pregnancy and what to do about it. The 2016 Birth and Babies Fair, Kellogg Center. Washington, DC. 5/01/16
Effects of perinatal disorders on fetus and child. Children’s National Medical Center Clinical Fellows’ Journal Club, Department of Psychiatry, Washington, D.C. 4/10/15
Women’s Mental Health. Milken Institute School of Public Health, George Washington University.   Washington, DC. 3/28/15*
Treatment Paradigms in Women’s Mental Health Disorders (workshop). NIMH Social Work Professional Development Group (CEU event).  Bethesda, MD.  2/11/15*
Sex Differences in Cognitive Performance: Effects of Induced Hypogonadism.  Neuroscience Conference, Department of Neurology, Mayo Clinic, Scottsdale, AZ. 3/19/2014*
Career workshop Panel Speaker: Strategizing & Surviving PhD/MD Programs, Division of Intramural Research 16th Annual Fellows’ Scientific Training Day, Bethesda, MD. 2/21/2014*
Sex Differences in Visuospatial Abilities are Maintained During Induced Hypogonadism.  American Neuropsychiatric Association Scientific Meeting oral presentation. Seattle, WA. 2/17/2014*
Art of Negotiation for Women (Invited panelist), Ladies America, Washington, DC.  1/7/2014
Effects of Reproductive Aging on Mood and Cognition in Women. Visiting Speaker Seminar, Department of Psychiatry, Mayo Clinic, Scottsdale, AZ. 6/2013
Current Research in Women’s Mental Health (Keynote Speaker). UNECOM Medicine Research Symposium, Biddeford, ME. 9/2012*
Pursuing a Career in Clinical Research (AOA CME).  NEOMEN, 11th Annual Research and Scholarship Forum, Biddeford, ME. 5/2012*
Postpartum Depression and Treatment. Postpartum Support International (PSI) Virginia Chapter, Falls Church, VA. 4/2012
Role of Hormones in Postpartum Depression. PSI, Maryland Chapter, Silver Springs, MD. 3/2012*
Role of Ovarian Steroids in Postpartum Depression, Psychiatry Clinical Fellows Seminar, 2/2012*

*This presentation was done as part of Dr. Guerrieri’s official FDA,NIH, or NIMH government duties. Dr. Guerrieri has no conflicts of interest to disclose.  Her private practice work is independent of any official government duty.

Comments are closed.